SavedAdd your journal

Journals / Türk Klinik Biyokimya Dergisi / 2016 / Cilt: 14 - Sayı: 3

Prostate Specific Antigen and Derivatives in Prostate Cancer Diagnosis

Prostat Kanseri Tanısında Prostat Spesifik Antijen ve Türevleri

Necati MUŞLU
Serin AKBAYIR
Pages
189–204
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was aimed to evaluate PSA and derivatives’s situation in prostate cancer diagnosis from past to present

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Search for other markers increase in prostate cancer diagnosis due to the lack of prostate-specific antigen, but it has not yet found more sensitive and specific method to make diagnosis by exposing patients less treatment.
📊
Key Findings & Data:Therefore, the sensitivity and specificity investigation of PSA derivatives in early diagnosis of prostate cancer continues, and different comparisons are made in researches to find the most accurate and exact diagnostic method.
💡
Conclusion & Impact:It was aimed to evaluate PSA and derivatives’s situation in prostate cancer diagnosis from past to present
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Search for other markers increase in prostate cancer diagnosis due to the lack of prostate-specific antigen, but it has not yet found more sensitive and specific method to make diagnosis by exposing patients less treatment. The exact diagnosis of prostate cancer continues to be made by prostate biopsy. Therefore, the sensitivity and specificity investigation of PSA derivatives in early diagnosis of prostate cancer continues, and different comparisons are made in researches to find the most accurate and exact diagnostic method. It was aimed to evaluate PSA and derivatives’s situation in prostate cancer diagnosis from past to present

Özet

Prostat spesifik antijenin eksiklikleri nedeniyle prostat kanseri tanısında başka belirteçlerin arayışı artsa da, henüz hastayı daha az işleme maruz bırakarak tanı koyduracak daha duyarlı ve özgül bir yöntem bulunamamıştır. Prostat kanserinin kesin tanısı da prostat biyopsisi ile konulmaya devam etmektedir. Bu nedenle, PSA'nın türevlerinin erken tanıdaki duyarlılık ve özgüllüğü araştırılmaya devam etmekte, farklı karşılaştırmalar yapılarak en doğru ve kesin tanıyı koyduracak yöntem için araştırmalar yapılmaktadır. PSA ve türevlerinin prostat kanseri tanısındaki durumunu geçmişten günümüze kadar değerlendirmek amaçlanmıştır

🔖

Cite This Article

MUŞLU, N., AKBAYIR, S. (2022). Prostate Specific Antigen and Derivatives in Prostate Cancer Diagnosis. Türk Klinik Biyokimya Dergisi, Cilt: 14 - Sayı: 3, 189–204. https://ajindex.com/articles/654948

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63(1):11-30
  2. Ablin RJ, Soanes WA, Bronson P, Witebsky E. Precipitating antigens of the normal human prostate. J Reprod Fertil 1970;22(3):573-4
  3. Kuriyama M, Wang MC, Papsidero LD, et al. Quantitiation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980;40(12):4658-62
  4. Kuriyama M, Wang MC, Lee CI, et al. Use of human prostate-specific antigen in monitoring of prostate cancer. Cancer Res 1981;41(10):3874-6
  5. Kervancıoğlu E, Koşan M. Prostat Kanseri Doku ve Serum Biyomarkerlarında Güncel Durum Değerlendirilmesi. Üroonkoloji Bülteni 2015;14:102-107
  6. Lilja H. Biology of prostate specific antigen. Urology 2003;62(5 Suppl 1):27-32
  7. Riegman PH, Vliestra RJ, Van Der Koput J, et al. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem Biophys Res Commun 1989;159(1):95-102
  8. Alkibay T, Gürocak S. Tümör immünolojisi ve tümör belirleyiciler. Anafarta K, Bedük Y, Arıkan N. Temel Üroloji
  9. Baskı. Ankara: Öncü Basımevi, 2007:687-698
  10. Balk SP, Ko YJ, Bubley GJ. Biology of prostate specific antigen. J Clin Oncol 2003;21(2):383-91
  11. Gretzer MB, Partin AW. PSA markers in prostate cancer detection. Urol Clin North Am 2003;30(4): 677-86
  12. Mikolajczyk SD, Song Y, Wong JR, Matson RS, Rittenhouse HG. Are multiple markers the future of prostate cancer diagnostics? Clin Biochem 2004;37(7):519-28
  13. Sokoll LJ, Chan DW, Mikolajczyk SD, et al. Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: Preliminary analysis. Urology 2003;61(2):274–6
  14. McGee RS, Herr JC. Human seminal vesicle-specific antigen is a substrate for prostate specific antigen (or P-30). Biol Reprod 1988;39(2):499-510
  15. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.J Clin Endocrinol Metab 1992;75(4):1046-53
  16. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostatespecific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993;192(2):940-7
  17. Iwamura M, Hellman J, Cockett AT, Lilja H, Gershagen S. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteo